Medications for Hallucinations in the Elderly

First-Line Medications: Atypical Antipsychotics

The American Academy of Family Physicians recommends atypical antipsychotics as the first-line pharmacological treatment for hallucinations in elderly patients due to their efficacy and reduced risk of extrapyramidal symptoms compared to typical antipsychotics 1, 2
Risperidone is recommended with an initial dosage of 0.25 mg per day at bedtime and a maximum of 2-3 mg per day, usually in divided doses, with caution for extrapyramidal symptoms at doses of 2 mg per day or higher 1, 2
Quetiapine is recommended with an initial dosage of 12.5 mg twice daily and a maximum of 200 mg twice daily, with advantages of being more sedating and less likely to cause extrapyramidal symptoms, but caution for orthostatic hypotension and dizziness 1, 2, 3
Olanzapine is recommended with an initial dosage of 2.5 mg per day at bedtime and a maximum of 10 mg per day, usually in divided doses, with caution for drowsiness and orthostatic hypotension 1, 2
Aripiprazole is recommended with an initial dosage of 5 mg once daily, with less likelihood of causing extrapyramidal symptoms, and a reduced dose in older patients and those with cytochrome P450 2D6 metabolism issues 1, 3

The American Geriatrics Society recommends haloperidol as a second-line medication, with an initial dosage of 0.5-1 mg orally or subcutaneously, and significant caution advised due to high risk of extrapyramidal symptoms and contraindication in Parkinson's disease or Lewy body dementia 1, 3, 4
Other typical antipsychotics, such as trifluoperazine, perphenazine, and loxapine, are recommended with caution due to high risk of side effects and risk of irreversible tardive dyskinesia 1, 2

The American Geriatrics Society recommends divalproex sodium for agitation with hallucinations, with an initial dosage of 125 mg twice daily and titration to therapeutic blood level, and monitoring of liver enzymes, platelets, and PT/PTT 1, 5
Trazodone is recommended with an initial dosage of 25 mg per day and a maximum of 200-400 mg per day in divided doses, with caution in patients with premature ventricular contractions 1, 5

The American Geriatrics Society recommends avoiding benzodiazepines as first-line treatment for hallucinations in elderly patients, unless specifically indicated for alcohol or benzodiazepine withdrawal, due to risk of worsening delirium and paradoxical agitation 4
Medication selection should be guided by underlying cause of hallucinations, patient's comorbidities and risk factors, and potential drug interactions 2, 3
Dosing principles include starting at the lowest possible dose, titrating gradually, and using the minimum effective dose for the shortest duration possible 3, 4
Monitoring requirements include regular assessment of efficacy and side effects, and monitoring for extrapyramidal symptoms, sedation, and orthostatic hypotension 1, 3